Home > Insider Trading > Filing (0001209191-13-033384)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197036	I Bruce Sachs	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-06-21	1,100	$74.81	103,510	No	4	S	Direct
Common Stock	Disposition	2013-06-21	4,500	$75.85	99,010	No	4	S	Direct
Common Stock	Disposition	2013-06-21	2,700	$76.53	96,310	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $74.81(range $74.27 to $75.24).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $75.85 (range $75.29 to $76.23).
Open market sales reported on this line occurred at a weighted average price of $76.53 (range $76.28 to $76.77).